Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 2, 2014, Pages 1146-1152

  Cai, Jia Chang ^a   Zhang, Rong ^a   Hu, Yan Yan ^a   Zhou, Hong Wei ^a   Chen, Gong Xiang ^a  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CARBAPENEM; CARBAPENEMASE; CARBAPENEMASE KPC 2; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; DNA FRAGMENT; ERTAPENEM; IMIPENEM; MEROPENEM; OUTER MEMBRANE PROTEIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHINA; ESCHERICHIA COLI; ESCHERICHIA COLI ST131; GENE STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHINA; DNA TRANSPOSABLE ELEMENTS; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION; HUMANS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PLASMIDS; POLYMERASE CHAIN REACTION; PORINS; SEQUENCE ANALYSIS, DNA;

EID: 84893440771     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00912-13     Document Type: Article

References (38)

1. Wang F, Zhu DM, Hu FP, Ruan FY, Ni YX, Sun JY, Xu YC, Zhang XJ, Hu YJ, Ai XM, Yu YS, Yang Q, Sun ZY, Li L, Jia B, Huang WX, Zhuo C, Su DH, Wei LH, Wu L, Zhang ZX, Ji P, Wang CQ, Xue JC, Zhang H, Li WH, Xu YH, Shen JL, Shan B, Du Y. 2010. CHINET 2009 surveillance of bacterial resistance in China. Chin. J. Infect. Chemother. 10:325-334. (In Chinese.)
2. Zhu DM, Wang F, Hu FP, Jiang XF, Ni YX, Sun JY, Xu YC, Zhang XJ, Hu YJ, Ai XM, Yu YS, Yang Q, Sun ZY, Chen ZJ, Jia B, Huang WX, Zhuo C, Su DH, Wei LH, Wu L, Zhang ZX, Ji P, Wang CQ, Wang AM, Zhang H, Kong J, Xu YH, Shen JL, Shan B, Du Y. 2011. CHINET 2010 surveillance of bacterial resistance in China. Chin. J. Infect. Chemother. 11:321-329. (In Chinese.)
3. Hu FP, Zhu DM, Wang F, Jiang XF, Yang Q, Xu YC, Zhang XJ, Sun ZY, Chen ZJ, Wang CQ, Wang AM, Ni YX, Sun JY, Yu YS, Lin J, Shan B, Du Y, Xu YH, Shen JL, Zhang H, Kong J, Zhuo C, Su DH, Zhang ZX, Ji P, Hu YJ, Ai XM, Huang WX, Jia B, Wei LH, Wu L. 2012. 2011 CHINET surveillance of bacterial resistance in China. Chin. J. Infect. Chemother. 12:321-329. (In Chinese.)
4. Nordmann P, Cuzon G, Naas T. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228-236. http://dx.doi.org/10.1016/S1473-3099(09)70054-4.
5. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemaseproducing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798. http://dx.doi.org/10.3201/eid1710.110655.
6. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. 2007. Plasmidmediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob. Agents Chemother. 51:763-765. http://dx.doi.org/10.1128/AAC.01053-06.
7. Zhang R, Zhou HW, Cai JC, Chen GX. 2007. Plasmid-mediated carbapenem-hydrolysing-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J. Antimicrob. Chemother. 59:574-576. http://dx.doi.org/10.1093/jac/dkl541.
8. Zhang R, Yang L, Cai JC, Zhou HW, Chen GX. 2008. High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J. Med. Microbiol. 57:332-337. http://dx.doi.org/10.1099/jmm.0.47576-0.
9. Cai JC, Zhou HW, Zhang R, Chen GX. 2008. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob. Agents Chemother. 52:2014-2018. http://dx.doi.org/10.1128/AAC.01539-07.
10. Cai JC, Zhou HW, Chen GX, Zhang R. 2008. Detection of plasmidmediated carbapenem-hydrolyzing-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae. Zhonghua Yi Xue Za Zhi 88:135-138. (In Chinese.)
11. Hu YY, Cai JC, Zhang R, Zhou HW, Sun Q, Chen GX. 2012. Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese hospital. Antimicrob. Agents Chemother. 56:2278-2282. http://dx.doi.org/10.1128/AAC.05519-11.
12. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. 2012. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 25:682-707. http://dx.doi.org/10.1128/CMR.05035-11.
13. Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. 2011. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J. Antimicrob. Chemother. 66:307-312. http://dx.doi.org/10.1093/jac/dkq431.
14. Lee CM, Liao CH, Lee WS, Liu YC, Mu JJ, Lee MC, Hsueh PR. 2012. Outbreak of Klebsiella pneumoniae carbapenemase-2-producing K. pneumoniae sequence type 11 in Taiwan in 2011. Antimicrob. Agents Chemother. 56:5016-5022. http://dx.doi.org/10.1128/AAC.00878-12.
15. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14. http://dx.doi.org/10.1093/jac/dkq415.
16. Naas T, Cuzon G, Gaillot O, Courcol R, Nordmann P. 2011. When carbapenem-hydrolyzing-lactamase KPC meets Escherichia coli ST131 in France. Antimicrob. Agents Chemother. 55:4933-4934. http://dx.doi.org/10.1128/AAC.00719- 11.
17. Morris D, Boyle F, Ludden C, Condon I, Hale J, O'Connell N, Power L, Boo TW, Dhanji H, Lavallee C, Woodford N, Cormican M. 2011. Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob. Agents Chemother. 55:4935-4936. http://dx.doi.org/10.1128/AAC.05127-11.
18. Kim YA, Qureshi ZA, Adams-Haduch JM, Park YS, Shutt KA, Doi Y. 2012. Features of infections due to Klebsiella pneumoniae carbapenemaseproducing Escherichia coli: emergence of sequence type 131. Clin. Infect. Dis. 55:224-231. http://dx.doi.org/10.1093/cid/cis387.
19. Mavroidi A, Miriagou V, Malli E, Stefos A, Dalekos GN, Tzouvelekis LS, Petinaki E. 2012. Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2-lactamase. Int. J. Antimicrob. Agents 39:247-250. http://dx.doi.org/10. 1016/j.ijantimicag.2011.11.003.
20. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing: 21st informational supplement M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
21. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. 2001. Novel carbapenemhydrolyzing-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:1151-1161. http://dx.doi.org/10.1128/AAC.45.4.1151-1161. 2001.
22. Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, Wu JJ. 2001. Metallo-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 45:2224-2228. http://dx.doi.org/10.1128/AAC.45.8.2224-2228.2001.
23. Yu Y, Ji S, Chen Y, Zhou W, Wei Z, Li L, Ma Y. 2007. Resistance of strains producing extended-spectrum-lactamases and genotype distribution in China. J. Infect. 54:53-57. http://dx.doi.org/10.1016/j.jinf.2006.01.014.
24. Perez-Perez FJ, Hanson ND. 2002. Detection of plasmid-mediated AmpC-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162. http://dx.doi.org/10.1128/JCM.40.6.2153-2162.2002.
25. Hernandez-Alles S, Alberti S, Alvarez D, Domenech-Sanchez A, Martinez-Martinez L, Gil J, Tomas JM, Benedi VJ. 1999. Porin expression in clinical isolates of Klebsiella pneumoniae. Microbiology 145(Part 3):673-679. http://dx.doi.org/10.1099/13500872-145-3-673.
26. Poirel L, Heritier C, Spicq C, Nordmann P. 2004. In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J. Clin. Microbiol. 42:3831-3833. http://dx.doi.org/10.1128/JCM.42.8.3831-3833.2004.
27. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
28. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, Achtman M. 2006. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60: 1136-1151. http://dx.doi.org/10.1111/j.1365-2958.2006.05172.x.
29. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558. http://dx.doi.org/10.1128/AEM.66.10.4555-4558.2000.
30. Shen P, Wei Z, Jiang Y, Du X, Ji S, Yu Y, Li L. 2009. Novel genetic environment of the carbapenem-hydrolyzing-lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob. Agents Chemother. 53:4333-4338. http://dx.doi.org/10.1128/AAC.00260-09.
31. Bratu S, Brooks S, Burney S, Kochar S, Gupta J, Landman D, Quale J. 2007. Detection and spread of Escherichia coli possessing the plasmidborne carbapenemase KPC-2 in Brooklyn, New York. Clin. Infect. Dis. 44:972-975. http://dx.doi.org/10.1086/512370.
32. Urban C, Bradford PA, Tuckman M, Segal-Maurer S, Wehbeh W, Grenner L, Colon-Urban R, Mariano N, Rahal JJ. 2008. Carbapenemresistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase-lactamases associated with long-term care facilities. Clin. Infect. Dis. 46:e127-e130. http://dx.doi.org/ 10.1086/588048.
33. Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwaber MJ, Schwartz D, Carmeli Y. 2006. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob. Agents Chemother. 50:3098-3101. http://dx.doi.org/10.1128/AAC.00438-06.
34. Goren MG, Navon-Venezia S, Chmelnitsky I, Carmeli Y. 2010. Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv medical center, 2005 to 2008. Antimicrob. Agents Chemother. 54:2687-2691. http://dx.doi.org/10.1128/AAC.01359-09.
35. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Canton R, Nordmann P. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum-lactamase CTXM-11. Emerg. Infect. Dis. 14:195-200. http://dx.doi.org/10.3201/eid1402.070350.
36. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park YJ, Lavigne JP, Pitout J, Johnson JR. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
37. Sidjabat HE, Paterson DL, Adams-Haduch JM, Ewan L, Pasculle AW, Muto CA, Tian GB, Doi Y. 2009. Molecular epidemiology of CTX-Mproducing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob. Agents Chemother. 53:4733-4739. http://dx.doi.org/10.1128/AAC.00533-09.
38. Mushtaq S, Irfan S, Sarma JB, Doumith M, Pike R, Pitout J, Livermore DM, Woodford N. 2011. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J. Antimicrob. Chemother. 66: 2002-2005. http://dx.doi.org/10.1093/jac/dkr226.